Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease

被引：0
|
作者：
Rascol, O.
Poewe, W.
Stocchi, F.
Chaudhuri, R.
Kassube, J.
Manzanares, L. Lopez
Leta, V.
Zhang, I.
Bowling, A.
Wu, S.
Pappert, E.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
760
引用
收藏
页码：S348 / S348
页数：1
相关论文
共 50 条
  • [1] Efficacy of apomorphine sublingual film versus subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's Disease
    Stocchi, F.
    Rascol, O.
    Poewe, W.
    Chaudhuri, R.
    Kassubek, J.
    Manzanares, L. Lopez
    Leta, V.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    MOVEMENT DISORDERS, 2022, 37 : S356 - S356
  • [2] Efficacy, Safety, and Tolerability of Supratherapeutic Doses of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients With Parkinson's Disease
    Olanow, C.
    Stocchi, F.
    Wilks, K.
    Peckham, E.
    De Pandis, M.
    Sciarappa, K.
    Kleiman, R.
    Blum, D.
    Navia, B.
    MOVEMENT DISORDERS, 2019, 34
  • [3] Long-term Safety and Tolerability of Apomorphine Sublingual Film in Patients with Parkinson's Disease and "OFF" Episodes
    Ondo, William
    Ellenbogen, Aaron L.
    Isaacson, Stuart
    Espay, Alberto J.
    Bhargava, Parul
    Worden, MaryAlice
    Blum, David
    Navia, Bradford
    NEUROTHERAPEUTICS, 2019, 16 (03) : 913 - 913
  • [4] Apomorphine sublingual film versus subcutaneous apomorphine in the treatment of OFF episodes in Parkinson's disease: results from an assessment of patient satisfaction
    Schwarz, J.
    Carroll, C.
    Ebersbach, G.
    Kulisevsky, J.
    Tessitore, A.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    Thach, A.
    MOVEMENT DISORDERS, 2022, 37 : S352 - S352
  • [5] Safety and Tolerability of Apomorphine Sublingual Film During Maintenance Treatment in Patients With Parkinson's Disease and "OFF" Episodes: A Pooled Analysis
    Ondo, W.
    Ellenbogen, A.
    Isaacson, S.
    Espay, A.
    Singer, C.
    Bhargava, P.
    Worden, M.
    Blum, D.
    Navia, B.
    MOVEMENT DISORDERS, 2019, 34
  • [6] Safety and tolerability of apomorphine sublingual film during titration in patients with Parkinson's disease and "off" episodes: a pooled analysis
    Ondo, W.
    Ellenbogen, A.
    Isaacson, S.
    Espay, A.
    Singer, C.
    Bhargava, P.
    Worden, M.
    Blum, D.
    Navia, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 236 - 236
  • [7] Comparative bioavailability of apomorphine sublingual film and subcutaneous apomorphine formulations in patients with parkinson's disease and "OFF" episodes: preliminary results
    Agbo, F.
    Isaacson, S.
    Ellenbogen, A.
    Gil, R.
    Bhargava, P.
    Navia, B.
    Blum, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 445 - 445
  • [8] INDIRECT TREATMENT COMPARISONS OF APOMORPHINE SUBLINGUAL FILM VERSUS APOMORPHINE SUBCUTANEOUS INJECTION FOR THE ON-DEMAND TREATMENT OF "OFF" EPISODES IN PATIENTS WITH PARKINSON'S DISEASE
    Lenton, N.
    Singh, S.
    Szafranski, K.
    Situ, A.
    Thach, A.
    Pappert, E.
    Williams, G. R.
    VALUE IN HEALTH, 2020, 23 : S623 - S623
  • [9] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease: Impact on Dyskinesia
    Klos, K.
    Hui, J.
    Zhang, I.
    Pappert, E.
    Navia, B.
    MOVEMENT DISORDERS, 2021, 36 : S180 - S180
  • [10] Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson's Disease: An Open-Label, Randomized, Crossover Study
    Stocchi, Fabrizio
    Rascol, Olivier
    Poewe, Werner
    Chaudhuri, K. Ray
    Kassubek, Jan
    Lopez Manzanares, Lydia
    Zhang, Yi
    Bowling, Alyssa
    Pappert, Eric
    Wu, Stacy
    JOURNAL OF PARKINSONS DISEASE, 2023, 13 (08) : 1329 - 1342
12345